Yes, invasive fungal infection can absolutely be present despite a normal CT angiogram
A normal CT angiogram does NOT exclude invasive fungal infection. While CT angiography showing vessel occlusion is highly sensitive when positive, the absence of angioinvasive signs does not rule out fungal infection, particularly in early disease or non-angioinvasive forms.
Understanding the Diagnostic Limitations
CT Angiography Performance
The most recent high-quality research shows that CT pulmonary angiography (CTPA) detects vessel occlusion in only 80% of proven/probable invasive mold pneumonia cases 1. This means 20% of confirmed cases show NO vascular invasion signs on imaging. Earlier studies reported similar findings, with vessel occlusion detected in only 4 of 5 histologically proven angioinvasive cases 2.
Why CT Angio Can Be Normal Despite Active Infection
Early-stage disease: Angioinvasion develops over time. Initial fungal infection may not yet have invaded vessels when imaging is performed.
Non-angioinvasive patterns: Not all invasive fungal infections demonstrate angioinvasion. Some infections remain localized without vascular involvement initially.
Technical limitations: Small vessel involvement at the peripheral level may be below the resolution threshold of CT angiography.
Fungal type variations: While aspergillosis and mucormycosis are classically angioinvasive, the timing and extent of vascular involvement varies 3.
The Diagnostic Algorithm You Should Follow
1. Never rely on imaging alone
Current guidelines mandate a combination of multiple diagnostic methods with regular screening 4. A single normal CT angio is insufficient to exclude invasive fungal infection.
2. Implement serial testing protocols
- Aspergillus galactomannan testing: At least twice weekly during neutropenia 4
- Serum beta-D-glucan (BDG): Requires 2 or more levels for diagnosis 3
- Aspergillus-specific PCR: On blood or BAL samples 3
- Repeat imaging: Weekly chest X-ray or CT if clinically indicated 4
3. Pursue invasive diagnostics when suspicion remains high
Bronchoscopy with BAL is the diagnostic procedure of choice for pulmonary invasive fungal infections 3. This should be performed in patients with pulmonary signs/symptoms despite normal CT angio, as it allows:
- Direct fungal culture (though yield is often poor, especially for mucormycosis 3)
- Galactomannan testing on BAL fluid (higher sensitivity than serum)
- PCR testing (though cannot distinguish infection from colonization 3)
4. Clinical context overrides negative imaging
In immunocompromised patients with:
- Persistent fever beyond 48-72 hours despite broad-spectrum antibiotics 4
- Hematological malignancies
- Prolonged neutropenia (<500 cells/μL)
- Recent transplantation
Continue aggressive diagnostic workup even with normal CT angio, as the pre-test probability remains high.
Critical Pitfalls to Avoid
Do not stop antifungal therapy based solely on negative CT angio. Research shows that patients with negative CTPA had antifungal therapy stopped earlier, but 49% of those who couldn't be upgraded from "possible" to "probable" disease still had vessel occlusion on CTPA 5.
Do not delay bronchoscopy waiting for imaging changes. Diagnostic procedures should be repeated regularly and not delayed, even after initiating antifungal treatment 4.
Remember that chest imaging for mucormycosis is "varied and non-specific" 3, making it particularly unreliable for excluding this deadly infection.
The Bottom Line for Clinical Practice
In high-risk immunocompromised patients with persistent fever, proceed with the full diagnostic algorithm including bronchoscopy, serial biomarkers, and empiric antifungal therapy regardless of initial CT angio results. The sensitivity of vessel occlusion signs (80-100% when present 1, 5) means a positive finding is helpful, but negative findings cannot exclude disease given the 20% false-negative rate and the limitations of detecting early or non-angioinvasive infection.